MediWound stock climbs after 4Q revenue swells past Street estimates
MediWound Ltd (NASDAQ:MDWD) rose Monday after the biopharma focusing on severe burn and wound management posted a narrower fourth-quarter loss on strong revenue.
For the quarter ended December 2019, the Yavne, Israel-based company posted a loss of $0.06 per share on revenue of $1 million. The consensus estimate was a loss of $0.15 per share on revenue of $0.8 million. Revenue grew 87.2% on a year-over-year basis.
Shares in MediaWound climbed 7.5% to $5.58 before the opening bell.
READ: MediWound climbs after reporting positive results from Phase 3 burn treatment clinical study
In January, the company announced positive top-line results from the Phase 3 DETECT study in NexoBrid which removes dead tissue resulting from a severe burn.
MediWound plans to file a biologics license application for NexoBrid in the second half of 2019. A biologics license application is a request to distribute a biologic across states.
“We plan to file the biologics license application in the second half of 2019, subject to Food and Drug Administration concurrence in a meeting planned for the second quarter,” MediWound CEO Gal Cohen said in a statement.
Cohen announced earlier in March that he will step down as CEO by the end of May and that
The niche company specializes in developing therapeutics to treat conditions related to severe burns and chronic or slow-to-heal wounds.
Contact Uttara Choudhury at [email protected]
Follow her on Twitter: @UttaraProactive
Story by ProactiveInvestors
Source: https://www.proactiveinvestors.com/companies/news/217136/mediwound-stock-climbs-after-4q-revenue-swells-past-street-estimates-217136.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Lion’s Mane Mushroom
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, But it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes:
Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity.
Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins.
Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system.
Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome.
Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function.
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules. Today Be 100% Satisfied Or Receive A Full Money Back Guarantee Order Yours Today By Following This Link.